MARKET

SENS

SENS

SENSEONICS
AMEX

Real-time Quotes | Nasdaq Last Sale

0.3624
-0.0086
-2.32%
Closed 18:03 11/23 EST
OPEN
0.3727
PREV CLOSE
0.3710
HIGH
0.3758
LOW
0.3525
VOLUME
3.08M
TURNOVER
--
52 WEEK HIGH
1.780
52 WEEK LOW
0.3525
MARKET CAP
89.03M
P/E (TTM)
-0.7008
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Senseonics Holdings (SENS) Reports Q3 Loss, Lags Revenue Estimates
Zacks · 11/09 23:55
Senseonics EPS misses by $0.04, beats on revenue
Senseonics (SENS): Q3 GAAP EPS of -$0.10 misses by $0.04.Revenue of $0.77M (-82.2% Y/Y) beats by $0.23M.Cash, equivalents and restricted cash were $26.4M and outstanding indebtedness was $123.4M.Shares -4.74%.Press Release
Seekingalpha · 11/09 21:25
Senseonics Holdings, Inc. Common Stock Q3 EPS $(0.10) Misses $(0.06) Estimate, Sales $767.00K Beat $540.00K Estimate
Senseonics Holdings, Inc. Common Stock (AMEX:SENS) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.06) by 66.67 percent. This is unchanged from the same period last year.
Benzinga · 11/09 21:24
Senseonics Announces Equity Line of Credit Financing Agreement
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced entrance into an equity line of credit financing agreement with current shareholder Energy Capital, LLC for up to $12.0 million.
Business Wire · 11/09 21:04
Senseonics Holdings, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / November 9, 2020 / Senseonics Holdings, Inc.
ACCESSWIRE · 11/09 19:30
Will Senseonics Holdings (SENS) Report Negative Earnings Next Week? What You Should Know
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 11/02 17:31
Senseonics Announces Equity Grants To Employees Under Inducement Plan
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that it had made equity grants to new employees under its 2019 Inducement
Business Wire · 10/06 12:30
Senseonics files U.S. application to extend wearable life of glucose monitor
Senseonics (SENS) has filed a supplemental marketing application in the U.S. seeking approval to extend the wearable life of the Eversense CGM System to 180 days from the current 90
Seekingalpha · 10/05 11:46
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SENS. Analyze the recent business situations of SENSEONICS through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SENS stock price target is 0.8800 with a high estimate of 1.000 and a low estimate of 0.4000.
EPS
Institutional Holdings
Institutions: 117
Institutional Holdings: 93.52M
% Owned: 38.07%
Shares Outstanding: 245.67M
TypeInstitutionsShares
Increased
49
4.74M
New
13
3.28M
Decreased
18
5.37M
Sold Out
21
1.58M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.80%
Pharmaceuticals & Medical Research
-0.36%
Key Executives
Chairman/Independent Director
Stephen DeFalco
President/Chief Executive Officer/Director
Timothy Goodnow
Chief Financial Officer/Treasurer/Secretary
Nick Tressler
Chief Operating Officer
Mukul Jain
Vice President/General Manager
Mirasol Panlilio
Other/Director
Francine Kaufman
Director
Anthony Raab
Director
Robert Schumm
Independent Director
Steven Edelman
Independent Director
Edward Fiorentino
Independent Director
Peter Klein
Independent Director
Douglas Prince
Independent Director
Douglas Roeder
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SENS
Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company's Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user's mobile device, such as a smartphone, Apple Watch or tablet.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Senseonics Holdings Inc stock information, including AMEX:SENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SENS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SENS stock methods without spending real money on the virtual paper trading platform.